Antileishmanial drug discovery and development: time to reset the model?

AI Olias-Molero, C de la Fuente, M Cuquerella… - Microorganisms, 2021 - mdpi.com
Leishmaniasis is a vector-borne parasitic disease caused by Leishmania species. The
disease affects humans and animals, particularly dogs, provoking cutaneous …

Quinolone: a versatile therapeutic compound class

PS Dube, LJ Legoabe, RM Beteck - Molecular Diversity, 2023 - Springer
The discovery of nalidixic acid is one pinnacle in medicinal chemistry, which opened a new
area of research that has led to the discovery of several life-saving antimicrobial agents …

Recent advances in chemotherapeutics for leishmaniasis: Importance of the cellular biochemistry of the parasite and its molecular interaction with the host

R Singh, M Kashif, P Srivastava, PP Manna - Pathogens, 2023 - mdpi.com
Leishmaniasis, a category 1 neglected protozoan disease caused by a kinetoplastid
pathogen called Leishmania, is transmitted through dipteran insect vectors (phlebotomine …

[HTML][HTML] Sesquiterpenoids and flavonoids from Inula viscosa induce programmed cell death in kinetoplastids

I Zeouk, I Sifaoui, A López-Arencibia… - Biomedicine & …, 2020 - Elsevier
Neglected tropical diseases such as leishmaniasis and American trypanosomiasis represent
an increasing health problem. Current treatments are not satisfactory which remains an …

Development of chimeric protein as a multivalent vaccine for human Kinetoplastid infections: Chagas disease and leishmaniasis

M de Carvalho Clímaco, LA de Figueiredo, RC Lucas… - Vaccine, 2023 - Elsevier
Leishmania spp. and Trypanosoma cruzi are parasitic kinetoplastids of great medical and
epidemiological importance since they are responsible for thousands of deaths and …

[HTML][HTML] Multi-target withaferin-A analogues as promising anti-kinetoplastid agents through the programmed cell death

D San Nicolás-Hernández… - Biomedicine & …, 2023 - Elsevier
Leishmaniasis and Chagas disease, two of the most prevalent neglected tropical diseases,
are a world health problem. The harsh reality of these infective diseases is the absence of …

[HTML][HTML] Withaferin A-silyl ether analogs as potential anti-kinetoplastid agents targeting the programmed cell death

D San Nicolás-Hernández… - Biomedicine & …, 2023 - Elsevier
Current therapies of leishmaniasis and Chagas disease, two of the most widespread
neglected tropical diseases, have limited efficacy and toxic side effects. In this regard …

Funding for chagas disease: A 10-year (2009–2018) survey

LS Sangenito, MH Branquinha, ALS Santos - Tropical Medicine and …, 2020 - mdpi.com
Chagas disease was discovered in 1909 by the Brazilian scientist Carlos Chagas. After
more than 110 years, many outcomes have been achieved in all research fields; however …

[HTML][HTML] COVID-19 pandemic causes increased clinic visits with diagnosis of tegumentary leishmaniasis in Brazil in 2020

MC Andrade, PRF Bonan, E Hilan, NP Marques… - International Journal of …, 2021 - Elsevier
Abstract Coronavirus disease 2019 (COVID-19) protocols has reduced primary and
secondary health care for other diseases, such as leishmaniasis, a parasitic, endemic …

Mapping the morbidity and mortality of Chagas disease in an endemic area in Brazil

CA Medeiros, MBA Silva, ALS Oliveira… - Revista do Instituto de …, 2022 - SciELO Brasil
Chagas disease is among the 21 neglected diseases according to the World Health
Organization. This study aimed to investigate the morbidity and mortality distribution of …